These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 19733956
1. Prediction of pelvic pathology in subfertile women with combined Chlamydia antibody and CA-125 tests. Penninx J, Brandes M, de Bruin JP, Schneeberger PM, Hamilton CJ. Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):178-82. PubMed ID: 19733956 [Abstract] [Full Text] [Related]
2. Chlamydial antibody, as determined with an enzyme-linked immunosorbent assay, in tubal factor infertility. Minassian SS, Wu CH, Jungkind D, Gocial B, Filer RB, Glassner M. J Reprod Med; 1990 Feb; 35(2):141-5. PubMed ID: 2137537 [Abstract] [Full Text] [Related]
3. Chlamydial serology and histerosalpingography in predicting tubal disease in infertility patients. Fiçicioğlu C, Api M. Acta Eur Fertil; 1995 Feb; 26(3):109-12. PubMed ID: 9098470 [Abstract] [Full Text] [Related]
4. Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis antibody in predicting tubal pathology at laparoscopy. Ng EH, Tang OS, Ho PC. Hum Reprod; 2001 Apr; 16(4):775-9. PubMed ID: 11278232 [Abstract] [Full Text] [Related]
5. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings. Eschenbach DA, Wölner-Hanssen P, Hawes SE, Pavletic A, Paavonen J, Holmes KK. Obstet Gynecol; 1997 Feb; 89(2):184-92. PubMed ID: 9015018 [Abstract] [Full Text] [Related]
6. The role of chlamydia genus-specific and species-specific IgG antibody testing in predicting tubal disease in subfertile women. den Hartog JE, Land JA, Stassen FR, Slobbe-van Drunen ME, Kessels AG, Bruggeman CA. Hum Reprod; 2004 Jun; 19(6):1380-4. PubMed ID: 15105400 [Abstract] [Full Text] [Related]
7. The predictive value of medical history taking and Chlamydia IgG ELISA antibody testing (CAT) in the selection of subfertile women for diagnostic laparoscopy: a clinical prediction model approach. Coppus SF, Opmeer BC, Logan S, van der Veen F, Bhattacharya S, Mol BW. Hum Reprod; 2007 May; 22(5):1353-8. PubMed ID: 17234674 [Abstract] [Full Text] [Related]
8. Integration of patient characteristics and the results of Chlamydia antibody testing and hysterosalpingography in the diagnosis of tubal pathology: an individual patient data meta-analysis. Broeze KA, Opmeer BC, Coppus SF, Van Geloven N, Den Hartog JE, Land JA, Van der Linden PJ, Ng EH, Van der Steeg JW, Steures P, Van der Veen F, Mol BW. Hum Reprod; 2012 Oct; 27(10):2979-90. PubMed ID: 22851718 [Abstract] [Full Text] [Related]
9. Pelvic factor infertility: diagnosis and prognosis of various procedures. Bulletti C, Panzini I, Borini A, Coccia E, Setti PL, Palagiano A. Ann N Y Acad Sci; 2008 Apr; 1127():73-82. PubMed ID: 18443333 [Abstract] [Full Text] [Related]
10. [Chlamydia antibody testing for tubal factor subfertility]. Lardenoije CM, Land JA. Ned Tijdschr Geneeskd; 2007 Sep 08; 151(36):1981-5. PubMed ID: 17953171 [Abstract] [Full Text] [Related]
11. The value of Chlamydia trachomatis-specific IgG antibody testing and hysterosalpingography for predicting tubal pathology and occurrence of pregnancy. Perquin DA, Beersma MF, de Craen AJ, Helmerhorst FM. Fertil Steril; 2007 Jul 08; 88(1):224-6. PubMed ID: 17296194 [Abstract] [Full Text] [Related]
12. Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility. den Hartog JE, Land JA, Stassen FR, Kessels AG, Bruggeman CA. Hum Reprod; 2005 Apr 08; 20(4):986-90. PubMed ID: 15640255 [Abstract] [Full Text] [Related]
13. Evidence-based medicine for diagnostic questions. Evers JL, Land JA, Mol BW. Semin Reprod Med; 2003 Feb 08; 21(1):9-15. PubMed ID: 12806555 [Abstract] [Full Text] [Related]
14. Identifying subfertile ovulatory women for timely tubal patency testing: a clinical decision rule based on medical history. Coppus SF, Verhoeve HR, Opmeer BC, van der Steeg JW, Steures P, Eijkemans MJ, Hompes PG, Bossuyt PM, van der Veen F, Mol BW. Hum Reprod; 2007 Oct 08; 22(10):2685-92. PubMed ID: 17675647 [Abstract] [Full Text] [Related]
15. [The most suitable tests for studying chlamydial infection in women with sterility]. Borisov I, Nalbanski B, Filipov E, Pŭnevska M, Kolarov G. Akush Ginekol (Sofiia); 1999 Oct 08; 38(4):23-5. PubMed ID: 10726347 [Abstract] [Full Text] [Related]
16. The relationship between serum Chlamydia antibody levels and severity of disease in infertile women with tubal damage. El Hakim EA, Gordon UD, Akande VA. Arch Gynecol Obstet; 2010 Apr 08; 281(4):727-33. PubMed ID: 19760187 [Abstract] [Full Text] [Related]
17. [Correlation between CA-125 marker with the presence and severity of pelvic endometriosis]. Bianchi M, Macaya R, Durruty G, Manzur A. Rev Med Chil; 2003 Apr 08; 131(4):367-72. PubMed ID: 12870230 [Abstract] [Full Text] [Related]
18. Preoperative serum CA-125 and CA-72 in predicting endometriosis in infertility patients. Molo MW, Kelly M, Radwanska E, Binor Z. J Reprod Med; 1994 Dec 08; 39(12):964-6. PubMed ID: 7884754 [Abstract] [Full Text] [Related]
19. Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions. Somigliana E, Viganò P, Tirelli AS, Felicetta I, Torresani E, Vignali M, Di Blasio AM. Hum Reprod; 2004 Aug 08; 19(8):1871-6. PubMed ID: 15218003 [Abstract] [Full Text] [Related]
20. [Anti-C. trachomatis IgG antibodies levels in serum to identify infertility caused by tubal damage]. Hernández-Trejo M, López-Hurtado M, Arteaga-Troncoso G, Guerra-Infante FM. Rev Invest Clin; 2009 Aug 08; 61(1):87-9. PubMed ID: 19507478 [Abstract] [Full Text] [Related] Page: [Next] [New Search]